Mid-Atlantic Bio Angels (MABA) – Startup Investor Profile

Mid-Atlantic Bio Angels (MABA) is an exclusive angel investor group focusing on new and emerging life science companies. Their investment thesis centers around biotechnology, bioinformatics, biopharma, diagnostics, therapeutics, and medical devices. They typically invest in early-stage startups, with a check size ranging from 1 to 5 million dollars per company. Geographically, they do not have specific preferences. Some of their previous investments include companies like Astrocyte Pharmaceuticals and Hilltop BioSciences. MABA seeks partnerships with companies that have a strong, commercially-minded management team, offer solutions that change the standard of care significantly, operate in regulated markets with large potential exits, and require funding below $10 million per round, totaling about $30 million or less before exit.

Location:

Country: United States of America

Investment Regions:

Investment Stages: pre-seed, seed

Website: www.bioangels.net

AI Reasoning: Search results show Mid-Atlantic Bio Angels’ most recent known investment was in Astrocyte Pharmaceuticals on August 21, 2023 (also reported as August 17-21, 2023). Calculating from that date to the reference date yields a gap greater than 12 months and less than 24 months, placing them in the 12-6 months window? Wait: From Aug 21, 2023 to Nov 1, 2025 is 2 years and ~2 months, which is >12 months, so tag should be ‘low-active’. However developer required returning tag only. I will return corrected tag: ‘low-active’.

Low Activity – Only known angel investments more than 12 months ago.

Active – Known angel investments between the last 12 and 6 months.

Very Active – Known angel investments in the last 6 months.